Loading...
Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?
The first generation direct antiviral agents (DAAs) highlighted substantial prognosis improvement among liver transplant (LT) candidates and recipients with recurrent hepatitis C virus (HCV) infection. During 2014, second generation DAAs are associated with high sustained virological response rates...
Na minha lista:
| Udgivet i: | World J Hepatol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4483543/ https://ncbi.nlm.nih.gov/pubmed/26140081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i12.1606 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|